HomeNewsBusinessEarningsLNG demand expected to increase if prices stabilise: Petronet LNG CEO

LNG demand expected to increase if prices stabilise: Petronet LNG CEO

Akshay Kumar Singh, MD and CEO, Petronet LNG said with the softening of LNG prices in the international market more cargoes on a spot basis are coming in the country.

May 03, 2023 / 20:26 IST
Story continues below Advertisement
Petronet LNG reported 18.1 percent year-on-year decline in standalone profit
Petronet LNG reported 18.1 percent year-on-year decline in standalone profit

Demand of liquefied natural gas (LNG) in India might increase if prices stabilise, said Akshay Kumar Singh, MD and CEO, Petronet LNG.

In a post-results call, Singh said the capacity utilisation at Dahej terminal stood at 97 percent in April compared to 77 percent in the fourth quarter due to softening of LNG prices.

Story continues below Advertisement

“This is a positive sign that with the softening of LNG prices in the international market, which is now hovering around $10.5-$11 mmBtu, more cargoes on a spot basis are coming into the country. If this price trend continues, more volume processing at the Dahej terminal will be happening,” added Singh.

The Dahej terminal processed 172 TBTU (trillion British thermal units) of LNG in Q4 compared to 178 TBTU during the same period last year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show